News + Filings
Key Docs

Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Sight Sciences, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18
    Dry Eye  1.61.0 
    Surgical Glaucoma
Total revenues  27.623.37.5
            Revenue growth   [+]18.4%210.1% 
Cost of goods sold
Gross profit  18.416.85.2
            Gross margin  66.7%72.0%69.0%
Selling, general and administrative  41.732.714.1
Research and development
EBITDA   [+]-31.6-23.7-14.2
            EBITDA margin  -114.5%-101.7%-189.0%
Depreciation and amortization
EBIT   [+]-32.2-24.0-14.3
            EBIT margin  -116.5%-103.0%-189.9%
Interest expense, net   [+]
Other income (expense), net  -0.10.0 
Pre-tax income  -34.6-25.9-14.3
Income taxes
            Tax rate    0.0%
Net income
            Net margin  0.0%0.0%0.0%
Basic EPS  $0.00$0.00$0.00
Diluted EPS  $0.00$0.00$0.00
Shares outstanding (basic)   [+]9,356.29,387.19,222.7
Shares outstanding (diluted)   [+]9,356.29,387.19,222.7
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy